Oncolytic HSV and PI3K inhibitor BKM120 synergize to promote killing of prostate cancer stem-like cells.

被引：0
|
作者：
Wang, Lei [1 ]
机构：
[1] Wuhan Univ, Zhongnan Hosp, Wuhan, Hubei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e16503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16503
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II study of the PI3K inhibitor BKM120 monotherapy in patients with advanced or recurrent endometrial carcinoma: ENDOPIK, GINECO Study.
    Heudel, Pierre-Etienne
    Fabbro, Michel
    Roemer-Becuwe, Celia
    Treilleux, Isabelle
    Kaminsky, Marie-Christine
    Arnaud, Antoine
    Joly, Florence
    Forestier, Sophie Roche
    Herve, Robert
    Ray-Coquard, Isabelle
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] A phase I trial of mFOLFOX6 combined with the oral PI3K inhibitor BKM120 in patients with advanced refractory solid tumors
    McRee, Autumn J.
    Sanoff, Hanna K.
    Carlson, Cheryl
    Ivanova, Anastasia
    O'Neil, Bert H.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (06) : 1225 - 1231
  • [33] The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
    Dubrovska, Anna
    Kim, Sungeun
    Salamone, Richard J.
    Walker, John R.
    Maira, Sauveur-Michel
    Garcia-Echeverria, Carlos
    Schultz, Peter G.
    Reddy, Venkateshwar A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (01) : 268 - 273
  • [34] A phase I trial of mFOLFOX6 combined with the oral PI3K inhibitor BKM120 in patients with advanced refractory solid tumors
    Autumn J. McRee
    Hanna K. Sanoff
    Cheryl Carlson
    Anastasia Ivanova
    Bert H. O’Neil
    Investigational New Drugs, 2015, 33 : 1225 - 1231
  • [35] Effects of the Specific PI3K Inhibitor BKM120, the Dual PI3K/mTOR Inhibitor BEZ235, and Specific mTOR Inhibitors Everolimus and Temsirolimus in Renal and Hepatic Carcinoma Models Resistant to Sunitinib and Sorafenib
    Serova, M.
    Raballand, A.
    Dos Santos, C.
    Riveiro, E.
    Raymond, E.
    Faivre, S.
    de Gramont, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 113 - 113
  • [36] Plasticity between the cancer stem-like and non cancer stem-like states is regulated by the PI3K/Akt/β-catenin/CBP pathway
    He, Kaijie
    Xu, Tong
    Xu, Yucheng
    Kahn, Michael
    Goldkorn, Amir
    CANCER RESEARCH, 2012, 72
  • [37] Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal
    Chen, Zhixing
    Yang, Hui
    Zhang, Qianlu
    Hu, Qiongying
    Zhao, Ziyi
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [38] Inhibition of PI3K/AKT signaling using BKM120 reduced the proliferation and migration potentials of colorectal cancer cells and enhanced cisplatin-induced cytotoxicity
    Khameneh, Sepideh Chodary
    Sari, Soyar
    Razi, Sara
    Yousefi, Amir-Mohammad
    Bashash, Davood
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [39] An exploratory analysis of inactivation of PI3K/AKT/mTOR signaling pathway using neoadjuvant BKM120 in PI3KCA mutated early breast cancer
    Estevez, L. G.
    Suarez, A.
    Calvo, I.
    Fernandez-Abad, M.
    Perea, S.
    Hidalgo, M.
    CANCER RESEARCH, 2013, 73
  • [40] Analysis of inactivation of PI3K/AKT/mTOR signaling pathway using neoadjuvant BKM120 in PI3KCA mutated early breast cancer.
    Laura, Estevez G.
    Ana, Suarez
    Isabel, Calvo
    Fernandez Abad, Maria
    Perea, Sofia
    Hidalgo, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345